Seres Therapeutics
MCRB
MCRB
94 hedge funds and large institutions have $382M invested in Seres Therapeutics in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
58% less capital invested
Capital invested by funds: $916M → $382M (-$534M)
73% less call options, than puts
Call options by funds: $713K | Put options by funds: $2.61M
Holders
94
Holding in Top 10
1
Calls
$713K
Puts
$2.61M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$6.34M | |
| 3 | +$4.1M | |
| 4 |
Renaissance Technologies
New York
|
+$3.64M |
| 5 |
AG
Artal Group
Luxembourg
|
+$2.34M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$18.1M | |
| 3 | -$14.3M | |
| 4 |
CCI
Columbus Circle Investors
|
-$10.7M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.35M |